SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMC NEWS

TMCNET eNEWSLETTER SIGNUP

Cocrystal Pharma Inc. to Present at Noble Capital Markets' 16th Annual Investor Conference
[February 11, 2020]

Cocrystal Pharma Inc. to Present at Noble Capital Markets' 16th Annual Investor Conference


– Presentation on Tuesday, February 18th at 11:30 AM ET –

BOTHELL, WA, Feb. 11, 2020 (GLOBE NEWSWIRE) -- COCRYSTAL PHARMA, INC. (NASDAQ: COCP) (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral therapeutics, today announced that Dr. Gary Wilcox, Chairman and Chief Executive Officer of Cocrystal, will present at NobleCon16 - Noble Capital Markets’ 16th Annual Investor Conference on Tuesday, February 18, 2020 at 11:30 a.m. ET in Hollywood, Florida.

In addition to the presentation, management will also be available to participate in one-on-one meetings with qulified members of the investor community who are registered to attend the conference. To request a meeting, please contact the NobleCon16 one-on-one desk.




About Cocrystal Pharma, Inc.

Cocrystal Pharma, Inc. is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. Cocrystal employs unique structure-based technologies and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs. For further information about Cocrystal, please visit www.cocrystalpharma.com.


Investor and Media Contact:
JTC Team, LLC
(833) 475-8247
COCP@jtcir.com

Primary Logo


[ Back To TMCnet.com's Homepage ]









Technology Marketing Corporation

2 Trap Falls Road Suite 106, Shelton, CT 06484 USA
Ph: +1-203-852-6800, 800-243-6002

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2020 Technology Marketing Corporation. All rights reserved | Privacy Policy